BIZILY SCOTT (Chief Legal Officer) sold 31.3% of their position (1.64K shares) of 4D MOLECULAR THERAPEUTICS, INC. on the open market
Open‑market sale worth $17.8K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/19/2025ACC: 0001193125-25-326851
Officer· Chief Legal Officer
Since Mar 2022
-1.64K
Net shares
Net seller
$17.8K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1.64K acquired · 3.27K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.64K
Price / share
$4.14
Trade value
$6.77K
% of position
45.5%
12/16/2025
3.59K→5.23K
Common Stock
Direct
Shares
−1.64K
Price / share
$10.90
Trade value
$17.82K
% of position
31.3%
12/16/2025
5.23K→3.59K
Total
Net shares
+0.00
Net value
-$11.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/16/2025 | M · Option Exercise | +1.64K | $4.14 | $6.77K | 45.5% | 3.59K | 5.23K |
| Common Stock Direct | 12/16/2025 | S · Sale | −1.64K | $10.90 | $17.82K | 31.3% | 5.23K | 3.59K |
| Total | +0.00 | -$11.05K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
1.64K shares
Shares
−1.64K
Strike price
4.14
Held after
73.59K
Exercisable
—
12/16/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock1.64K shares | 12/16/2025 | M · Option Exercise | −1.64K | 4.14 | — | 73.59K |